Table 2.

Differences in the analyte distributions in controls and fibrotic or cirrhotic disease groups.

Marker	Mean ± SD			p value
	CTRL	FIB	CIR	ANOVA (Kruskal–Wallis)
G0	7955 ± 3670	12,648 ± 4832	16,861 ± 8479	0.001 (0.001)
G0N	41,232 ± 22,263	69,968 ± 31,380	98,070 ± 52,119	0.001 (0.001)
G0F	53,845 ± 23,051	105,243 ± 38,999	133,037 ± 63,708	< 0.001 (< 0.001)
G0FN	19,124 ± 9444	47,675 ± 22,405	57,712 ± 19,918	< 0.001 (< 0.001)
G1	7278 ± 2825	9044 ± 2242	11,782 ± 3796	0.001 (0.003)
G1N	44,160 ± 18,270	49,241 ± 15,714	67,025 ± 29,678	0.018 (0.077)
G1F	72,900 ± 24,774	88,383 ± 21,241	110,607 ± 39,967	0.005 (0.012)
G1FN	10,280 ± 3953	16,698 ± 6450	20,071 ± 3816	< 0.001 (< 0.001)
Mono-sialyated-HPX	150,977,194 ± 42,469,521	106,900,429 ± 39,350,120	78,181,642 ± 34,237,671	< 0.001 (< 0.001)
di-sialyated-HPX	30,787,118 ± 9,482,062	30,177,484 ± 10,252,754	39,805,422 ± 10,405,085	0.020 (0.011)
S-HPX	0.09 ± 0.0296	0.173 ± 0.163	0.349 ± 0.188	< 0.001 (< 0.001)